Michael Konig in Manhasset, New York

Additional Medical Specialties Include:
CRITICAL CARE (INTENSIVISTS), INTERNAL MEDICINE

Medical School: New York College Of Osteo Medicine Of New York Institute Of Technology
Graduation Year: 2005
The Primary Medical Specialty for Michael Konig is listed as: Cardiovascular Disease (cardiology)
Approximate Years of Experience: 19
PAC (PECOS ID)#: 0648427062
NPI #: 1710172358
NPI Created On: 09/06/2007
NPI Last Updated Listed as: 02/28/2012
Primary Taxonomy Code: 390200000X
Listed Gender: Male

Forms of insurance accepted by include, but are not limited to:

• Humana
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

1. Insertion of needle into vein for collection of blood sample
2. Nuclear medicine study of vessels of heart using drugs or exercise multiple studies
3. Vaccine for influenza for administration into muscle, 0.5 ml dosage
4. Routine ekg using at least 12 leads including interpretation and report
5. Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician supervision, interpretation, and report
6. Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function
7. Follow-up or limited ultrasound examination of heart
8. Follow-up or limited heart doppler ultrasound study of heart blood flow, valves, and chambers
9. Doppler ultrasound study of color-directed heart blood flow, rate, and valve function
10. Injection of drug or substance into a vein for therapy, diagnosis, or prevention
11. New patient office or other outpatient visit, typically 45 minutes
12. Established patient office or other outpatient visit, typically 15 minutes
13. Established patient office or other outpatient, visit typically 25 minutes
14. Initial hospital inpatient care, typically 70 minutes per day
15. Subsequent hospital inpatient care, typically 25 minutes per day
16. Physician telephone patient service, 11-20 minutes of medical discussion
17. Technetium tc-99m sestamibi, diagnostic, per study dose
18. Administration of influenza virus vaccine
19. Injection, aminophyllin, up to 250 mg
20. Injection, regadenoson, 0.1 mg